Exceptional negative changes in XBiotech Inc (NASDAQ: XBIT) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, and negative upside/downside volume developed.
XBiotech Inc (NASDAQ: XBIT) has recently experienced small negative changes in fundamentals: the stock’s power rating fell below 50.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
XBiotech has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. XBiotech has a slightly negative Power Rating of 34 and a poor Appreciation Score of 28, producing the Negative Value Trend Rating.
Recent Price Action
XBiotech Inc (NASDAQ: XBIT) stock closed at $6.66 on 11/15/24 after a decline of -4.4%. Moreover, trading volume in this decline was exceptionally high at 200% of normal. The stock has declined -9.5% during the last week and has performed in line with the market over the last nine months.
Be the first to comment